Lobbying

Bluejay Diagnostics BJDX's latest lobbying report covers Q2 2023, at $30K. Its first report covers Q2 2023; the issues it reports most are Health Issues.

Bluejay DiagnosticsBJDX

Bluejay Diagnostics stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

Bluejay Diagnostics lobbying by quarter
Bluejay Diagnostics lobbying by quarter
QuarterAmountReports
Q2 2023$30K1
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$30K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Platinum Advisors DC$30K1 quarters

Former officials lobbying for it

Former position
WILLIAM TRANGHESELegislative Assistant, Communications Director, Chief of Staff - Rep. Richard NealQ2 2023

Lobbying reports

Filed by
23/07/20for Q2 2023Platinum Advisors DC$30K
23/04/27for Q2 2023Platinum Advisors DCUnder $5,000